May 14, 2012
Eisai announced on May 11 that its US subsidiary Eisai Inc. had reached an agreement with Arena Pharmaceutical GmbH, the Swiss subsidiary of the US-based biopharmaceutical company Arena Pharmaceuticals, Inc., to change and expand an exclusive commercial license contract on...read more